Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Check-Cap ( (CHEK) ) has provided an announcement.
Check-Cap Ltd. has received a letter from Nasdaq, indicating non-compliance with the minimum bid price requirement, as its ordinary shares have fallen below the $1 threshold. The company has a 180-day compliance period until June 30, 2025, to meet the requirement by maintaining a $1 bid price for at least ten consecutive days, or face potential delisting from the Nasdaq exchange if the deficiency is not cured.
More about Check-Cap
Check-Cap Ltd. operates in the medical technology industry, focusing on the development of innovative imaging solutions. The company is primarily known for its capsule-based system designed to detect polyps before they transform into colorectal cancer, emphasizing non-invasive screening methods.
YTD Price Performance: -44.71%
Average Trading Volume: 741,748
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $6.73M
For a thorough assessment of CHEK stock, go to TipRanks’ Stock Analysis page.
